Professor Gagandeep Kang, Executive Director, Translational Health Science and Technology Institute (THSTI) in India, declares that all those who participate in clinical trials is a partner and considered champions of the health cause.
The Translational Health Science and Technology Institute (THSTI) is a society registered under the Societies Registration Act of XXI of 1860. It is also an autonomous institute of the Department of Biotechnology, Ministry of Science and Technology, Government of India. It was set up in 2009 at Gurgaon and now is located in NCR Biotech Science Cluster, Faridabad, along with the Regional Center for Biotechnology, Advanced Technology Platforms Center, and other research institutes. THSTI has six intramural centers, including Vaccine & Infectious Disease Research Centre (VIDRC), Pediatric Biology Centre (PBC), Centre for Bio-design & Diagnostics (CBD), Centre for Human Microbial Ecology (CHME), Policy Centre for Biomedical Research (PCBR), and Drug Discovery Research Centre (DDRC).
Professor Kang Speaks at a Clinical Research Conference
Professor Kang, an Infosys Prize Winner for Life Sciences and the first Indian women to be elected the Fellow of Royal Society in 2019, delivers keynote on “Trials and Tribulations: Clinical Research in India” on Day 1 of the XIV International Conference on Public Policy and Management organized by the Centre for public Policy (CPP) at Indian Institute of Management Bangalore (IIM-B).
Key Elements for Success in Clinical Research
Trust is first and foremost a necessity for the advancement of clinical research. Moreover, clinical trials must be conducted ethically and responsibly where not only is the information shared with the patient but also the community. Overall factors that Professor Kang have found are important for clinical research program success:
- Identification of needs in public health research
- Partners who provided appropriate training
- Targeted and monitored mentoring, commitment to the communities that professionals work in as well as commitment to quality
- Building multidisciplinary research groups of young faculty, availability of academic positions and funding
- Working in collaboration with government and like-minded institutions
- More investment in R&D
- New initiatives in public health
She said that lack of value systems, sclerotic bureaucracy, hierarchy, restrictive policies, and lack of institutional support were some of the challenges of clinical research.
“Going forward, we need to focus on setting priorities, looking at evaluating effectiveness, access, and healthcare management. As academicians, we need to help the Government in setting priorities, carry research, translate results into practice in India, and extend and reinforce research and training,” she said.
Prof Kang added, “High quality clinical research is being and can be done in India. Policies can be changed with planning and evidence accumulation”.
Professor Gagandeep Kang, Executive Director, Translational Health Science and Technology Institute (THSTI)
Call to Action: Are you interested in expanding to India or understanding research initiatives there? Contact Professor Kang. Do you need help with outreach—contact us and we can help you.Source: The Hindu Business Line